Data di Pubblicazione:
2015
Abstract:
The response of myeloproliferative neoplasms
with PCM1-JAK2 fusion genes can be long-lived, without use of allogeneic bone marrow transplantation
with PCM1-JAK2 fusion genes can be long-lived, without use of allogeneic bone marrow transplantation
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
CEL, jak2, ruxolitinib
Elenco autori:
Rumi, Elisa; Milosevic, Jd; Selleslag, D; Casetti, I; Lierman, E; Pietra, D; Cavalloni, C; Bellini, M; Milanesi, C; Dambruoso, I; Astori, C; Kralovics, R; Vandenberghe, P; Cazzola, Mario; 4, .
Link alla scheda completa:
Pubblicato in: